Skip to main content

Advertisement

SpringerLink
Log in

Glucose-Modulated Transgene Expression via Recombinant Adeno-Associated Virus

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Purpose. The objective of this study was to examine glucose-modulated reporter gene expression via recombinant adeno-associated viral vectors both in vitro and in vivo.

Methods. Huh7 human hepatoma cells were transduced by recombinant adeno-associated virus (rAAV) vectors containing the luciferase gene under control of the rat insulin I gene promoter and a cytomegalovirus immediate-early promoter driving-enhanced green fluorescence protein gene. The reporter gene expression was evaluated by glucose stimulation either in the absence or presence of insulin secretagogues, including phorbol-12-myristate-13-acetate, dibutyryl cyclic AMP, and forskolin. In vivo studies were performed by injecting rAAV into the livers of streptozotocin-induced diabetic C57BL/6J mice followed by measurements of blood glucose concentration and luciferase activity assays 2 weeks after rAAV injection.

Results. At a multiplicity of infection of 500, approximately 66-69% of cells expressed enhanced green fluorescence protein at 48 h post-transduction. Luciferase activities, driven by the insulin gene promoter, in the rAAV-transduced hepatoma cells responded to millimolars of glucose. The addition of phorbol-12-myristate-13-acetate, dibutyryl cyclic AMP, and forskolin increased luciferase expression in the presence of either 1 mM or 25 mM glucose. The stimulation of luciferase activities by these substances was inhibited by the presence of 100 nM staurosporine. Exposure to increments of exogenous insulin up to 10-7 M inhibited luciferase gene expression in rAAV-transduced Huh7 cells. The in vivo experiments demonstrated good correlation between luciferase activities and blood glucose levels in streptozotocin-induced diabetic animals.

Conclusion. rAAV is a promising vector for hepatic gene therapy for diabetes. Glucose and insulin secretagogues modulated transgene expression in rAAV-transduced hepatoma cells, suggesting that conditions affecting insulin gene promoter function in pancreatic islet beta cells also affect transgene expression in human hepatoma cells conferred with insulin gene promoter. Results obtained from in vivo experiments demonstrated that glucose modulated transgene expression can be obtained in rAAV-treated diabetic C57BL/6J mice.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. D. Mitanchez, B. Doiron, R. Chen, and A. Kahn. Glucosestimulated genes and prospects of gene therapy for type I diabetes. Endocrine Rev. 18:520–540 (1997).

    Google Scholar 

  2. F. Levine and G. Leibowitz. Towards gene therapy of diabetes mellitus. Mol. Med. Today 5:165–171 (1999).

    Google Scholar 

  3. C. B. Newgard. Perspectives in diabetes. Cellular engineering and gene therapy strategies for insulin replacement in diabetes. Diabetes 43:341–350 (1994).

    Google Scholar 

  4. M. S. German. Glucose sensing in pancreatic islet beta cells: The key role of glucokinase and the glycolytic intermediates. Proc. Natl. Acad. Sci. USA 90:1781–1785 (1993).

    Google Scholar 

  5. M. S. German and J. Wang. The insulin gene contains multiple transcriptional elements that respond to glucose. Mol. Cell Biol. 14:4067–4075 (1994).

    Google Scholar 

  6. R. F. Santerre, R. A. Cook, R. M. Crisel, J. D. Sharp, R. J. Schmidt, D. C. Williams, and C. P. Wilson. Insulin synthesis in a clonal cell line of simian virus 40-transformed hamster pancreatic beta cells. Proc. Natl. Acad. Sci. USA 78:4339–4343 (1981).

    Google Scholar 

  7. H. Efrat, S. Linde, and H. Kofod. Beta-cell lines derived from transgenic mice expressing a hybrid insulin gene-oncogene. Proc. Natl. Acad. Sci. USA 85:9037–9041 (1988).

    Google Scholar 

  8. F. Radvanyi, S. Christgau, S. Baekkeskov, C. Jolicoeur, and D. Hanahan. Pancreatic ?-cell cultured from individual preneoplastic foci in a tumorigenesis pathway: A potentially general technique for isolating physiologically representative cell lines. Mol. Cell Biol. 13:4223–4232 (1993).

    Google Scholar 

  9. S. A. Clark, B. L. Burnham, and W. L. Chick. Modulation of glucose-induced insulin secretion from a rat clonal ?-cell line. Endocrinology 127:2779–2788 (1990).

    Google Scholar 

  10. R. Chen, B. Doiron, and A. Kahn. Glucose responsiveness of a reporter gene transduced into hepatocytic cells using a retroviral vector. FEBS Lett. 365:223–226 (1995).

    Google Scholar 

  11. A. Valera, C. Fillat, C. Costa, J. Sabater, J. Visa, A. Pujol, and F. Bosch. Regulated expression of human insulin in the liver of transgenic mice corrects diabetic alterations. FASEB J. 8:440–447 (1994).

    Google Scholar 

  12. A. M. Simpson, G. M. Marshall, B. E. Tuch, L. Maxwell, B. Szymanska, J. Tu, S. Beynon, M. A. Swan, and M. Camacho. Gene therapy of diabetes: glucose-stimulated insulin secretion in a human hepatoma cell line (HEPG2ins/g). Gene Ther. 4:1202–1215 (1997).

    Google Scholar 

  13. G. D. Simonson, D. J. Groskreutz, C. M. Gorman, and M. J. MacDonald. Synthesis and processing of genetically modified human proinsulin by rat myoblast in primary cultures. Hum. Gene Ther. 7:71–78 (1996).

    Google Scholar 

  14. L. Gros, L. Montoliu, E. Rui, L. Lebrigand, and F. Bosch. Regulated production of mature insulin by non-? cells. Hum. Gene Ther. 8:2249–2259 (1997).

    Google Scholar 

  15. L. Gros, E. Rui, L. Montoliu, O. Maria, L. Laurence, and F. Bosch. Insulin production by engineered muscle cells. Hum. Gene Ther. 10:1207–1217 (1999).

    Google Scholar 

  16. D. Lu, H. Hoshino, and T. Takeuchi. Regulatable production of mature insulin from a hepatocyte cell line: Insulin production is up-regulated by cAMP and glucocorticoids, and down-regulated by insulin. FEBS Lett. 399:37–42 (1996).

    Google Scholar 

  17. D. Lu, H. Tamemoto, H. Shibata, and T. Takeuchi. Regulatable production of insulin from primary-cultured hepatocytes: Insulin production is up-regulated by glucagon and cAMP and downregulated by insulin. Gene Ther. 5:888–895 (1998).

    Google Scholar 

  18. M. Tiedge, M. Elsner, N. H. McClenaghan, H.-J. Hedrich, D. Grube, J. Klempnauer, and S. Lenzen. Engineering of a glucoseresponsive surrogate cell for insulin replacement therapy of experimental insulin-dependent diabetes. Hum. Gene Ther. 11:403–414 (2000).

    Google Scholar 

  19. P. M. Thulé, J. Liu, and L. S. Phillips. Glucose regulated production of human insulin in rat hepatocytes. Gene Ther. 7:205–214 (2000).

    Google Scholar 

  20. G. Podsakoff, Jr. K. K. Wong, and S. Chatterjee. Efficient gene transfer into nondividing cells by adeno-associated virus-based vectors. J. Virol. 68:5656–5666 (1994).

    Google Scholar 

  21. D. W. Russell, A. D. Miller, and I. E. Alexander. Adenoassociated virus vectors preferentially transduce cells in S phase. Proc. Natl. Acad. Sci. USA 91:8915–8919 (1994).

    Google Scholar 

  22. R. M. Kotin. Prospects for the use of adeno-associated virus as a vector for human gene therapy. Hum. Gene Ther 5:793–801 (1994).

    Google Scholar 

  23. T. R. Flotte and B. J. Carter. Adeno-associated virus vectors for gene therapy. Gene Ther. 2:357–362 (1995).

    Google Scholar 

  24. Y.-W. Yang and R. M. Kotin. Glucose-responsive gene delivery in pancreatic islet cells via recombinant adeno-associated viral vectors. Pharm. Res. 17:1056–1061 (2000).

    Google Scholar 

  25. G. G. Holz and J. F. Habener. Signal transduction crosstalk in the endocrine system: pancreatic ?-cells and the glucose competence concept. Trends Biochem. Sci 17:388–393 (1992).

    Google Scholar 

  26. Y.-W. Yang and Y.-C. Hsieh. Protamine sulfate enhances the transduction efficiency of recombinant adeno-associated virusmediated gene delivery. Pharm. Res. 18:922–927 (2001).

    Google Scholar 

  27. S. J. H. Ashcroft, P. Hammonds, and D. E. Harrison. Insulin secretory responses of a clonal cell line of simian virus 40-transformed B cells. Diabetologia 29:727–733 (1986).

    Google Scholar 

  28. S. Goodison, S. Kenna, and S. J. H. Ashcroft. Control of insulin gene expression by glucose. Biochem. J. 285:563–568 (1992).

    Google Scholar 

  29. B. Leibiger, T. Moede, T. Schwarz, and G. R. Brown. Short-term regulation of mature insulin gene transcription by glucose. Proc. Natl. Acad. Sci. USA 95:9307–9312 (1998).

    Google Scholar 

  30. P. B. Daniel, W. H. Walker, and J. F. Habener. Cyclic AMP signaling and gene regulation. Annu. Rev. Nutr 18:353–383 (1998).

    Google Scholar 

  31. A. Eggers, G. Siemann, R. Blume, and W. Knepel. Gene-specific transcriptional activity of the insulin cAMP-response element is conferred by NF-Y in combination with cAMP response elementbinding protein. J. Biol. Chem 273:18499–18508 (1998).

    Google Scholar 

  32. W. Yu, T. Niwa, T. Fukasawa, H. Hidaka, T. Senda, Y. Sasaki, and I. Niki. Synergism of protein kinase A, protein kinase C, and myosin light-chain kinase in the secretory cascade of the pancreatic ?-cell. Diabetes 49:945–952 (2000).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. School of Pharmacy, College of Medicine, National Taiwan University, 1, Room 1214, Jen-Ai Road, Section 1, Taipei, 100, Taiwan

    Ya-Wun Yang, Yuan-Chiao Hsieh & Chih-Kai Chao

Authors
  1. Ya-Wun Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yuan-Chiao Hsieh
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Chih-Kai Chao
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ya-Wun Yang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yang, YW., Hsieh, YC. & Chao, CK. Glucose-Modulated Transgene Expression via Recombinant Adeno-Associated Virus. Pharm Res 19, 968–975 (2002). https://doi.org/10.1023/A:1016410221197

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1016410221197

Search

Navigation